Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma
Background CDK4 is highly expressed and associated with poor prognosis and decreased survival in advanced neuroblastoma (NB). Targeting CDK4 degradation presents a potentially promising therapeutic strategy compared to conventional CDK4 inhibitors. However, the autophagic degradation of the CDK4 pro...
Saved in:
| Main Authors: | Zhen Liu, Xiao-Yang Wang, Han-Wei Wang, Shan-Ling Liu, Chao Zhang, Feng Liu, Ying Guo, Feng-Hou Gao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Cancer Biology & Therapy |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15384047.2024.2385517 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vinblastine plus NVP-BEZ235 inducing apoptosis of human renal tumor cells
by: QIN Dan, et al.
Published: (2018-01-01) -
Dual PI3K/mTOR inhibitor NVP-BEZ235 induces cell cycle arrest via autophagy mediated protein degradation of RPL19 in nephroblastoma cell
by: Yan Gao, et al.
Published: (2025-07-01) -
Nanoemulsification of PTX and BEZ235 inhibits colon cancer growth
by: Xingyao Zhu, et al.
Published: (2025-05-01) -
Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
by: Miriam Franklin, et al.
Published: (2018-09-01) -
Understanding the Relation Between Intrinsic Parameters of Substituents and Physical‐Chemical Properties of NVP
by: S. Baiju, et al.
Published: (2024-12-01)